AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Modified Fluorescent Proteins for Detecting Protease Activity

Summary
Programmed cell death is a very important cellular process that is critically involved in many diseases. A key step in the programmed cell death is the activation of a series of intracellular proteases, such as caspase-3.

The invention is a novel method of detecting the early stage of programmed cell death in living cells. Green Fluorescent Protein (GFP) in the jellyfish Aequorea victoria is discovered to be used as a protein detector. When the cloned gene of GFP is expressed in host cells, it can produce an endogenous fluorescent protein without requiring adding converting enzymes or substrates. A molecular probe has been designed to assay the caspase activity by inserting the gene encoding the recognition sequence into the GFP gene. When this engineered gene is expressed in a cell, its gene product (a protein) will become a substrate of the specific caspase and can be cleaved by the caspase upon its activation and greatly change the fluorescent properties of the molecule. Such a change of fluorescence can be easily detected by optical means and thus can be used to assay whether the cells are undergoing programmed cell death or not.

Programmed cell death plays a critical role in many important diseases, including many types of cancer, AIDS, and auto-immune diseases. Drugs that can facilitate detection of programmed cell death in malfunctioning cells will be potentially useful in controlling these diseases. This invention thus will be highly useful to the pharmaceutical industry for rapid screening of drugs.
Technology Benefits
1. The detection procedure is extremely simple
2. Useful for large scale screening of drugs that can either promote or block programmed cell death
3. Easily adapted to detect activation of other proteases by changing the sensor sequence
Technology Application
- Drugs development for cancer, AIDS, and auto-immune diseases
- Can be used for drugs screening and toxicity tests
Supplementary Information
Patent Number: US7049400B1
Application Number: US2000551380A
Inventor: Chang, Donald Choy | Luo, Qian
Priority Date: 18 Apr 2000
Priority Number: US7049400B1
Application Date: 18 Apr 2000
Publication Date: 23 May 2006
IPC Current: C07K000100 | C12N000120 | C12N000900 | C12N000950 | C12N001500
US Class: 530350 | 435183 | 435212 | 435219 | 4352523 | 4353201
Assignee Applicant: The Hong Kong University of Science & Technology
Title: Modified fluorescent proteins for detecting protease activity
Usefulness: Modified fluorescent proteins for detecting protease activity
Summary: (I) is useful for detecting protease activity, and is particularly intended for use in detecting protease activity in living cells during apoptosis.
Novelty: Genetically engineered fluorescent protein incorporating a protease cleavage site, useful for detecting protease activity, and particularly for detecting caspase activity during apoptosis
Industry
Chemical/Material
Sub Category
Chemical/Material Application
Application Date
18 Apr 2000
Application No.
US 09/551380
Patent Information
US 7049400
ID No.
TTC.PA.100
Country/Region
Hong Kong

For more information, please click Here
Mobile Device